Skip to main content
SpringerLink
Log in

Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Recent studies have identified several single nucleotide polymorphisms (SNPs) in the population that are associated with variations in the risks of many different cancer diseases. For ovarian cancer, the known highly penetrant susceptibility genes (BRCA1 and BRCA2) are probably responsible for only 40 % of the excess familial ovarian cancer risks, suggesting that other susceptibility genes of lower penetrance exist. The aim of the present study was to evaluate the role of SNPs in three genes, XRCC2 (R188H), ERCC2 (K751Q) and CDKN1B (V109G) which are with moderate risk for ovarian cancer susceptibility in Egyptian women. We further investigated the potential combined effect of these genes variants on ovarian cancer risk. The three genes polymorphisms were characterized in 100 ovarian cancer Egyptian females and 100 healthy women by (RFLP–PCR) method in a case control study. Our results revealed that the frequencies of AC genotypes of ERCC2 (K751Q), and GG genotypes of CDKN1B (V109G) polymorphisms were significantly higher in EOC patients than in normal individual (P = 0.007, 0.02 respectively). The frequencies of AA genotype of XRCC2 (R188H) and CC genotype of ERCC2 (K751Q) were higher in EOC patients than in normal individual but without significance (P = 0.06, 0.38 respectively). Also, no association between any one of the three studied genes polymorphisms and the clinical characteristics of disease. The combination of GA (XRCC2) + AC (ERCC2) + GG (CDKN1B) was significantly associated with increased EOC risk. Also, the combination for GA (XRCC2) + AC (ERCC2) and the combination of AA (XRCC2) + CC (ERCC2) were significantly associated with increased EOC risk. There was significant difference in CA125 values between EOC and control Group (P < 0.001). Our results suggested that, XRCC2, ERCC2 and CDKN1B genes are important candidate genes for susceptibility to EOC. Also, gene–gene interaction between GA (XRCC2) + AC (ERCC2) + GG (CDKN1B) polymorphism may be associated with increased risk of EOCC in Egyptian women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Auranen A, Pukkala E, Makinen J, Sankila R, Grenman S (1996) Cancer incidence in the first-degree relatives of ovarian cancer patients. Br J Cancer 74:280–284

    Article  PubMed  CAS  Google Scholar 

  2. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J et al (2000) Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85

    Article  PubMed  CAS  Google Scholar 

  3. Ford D, Easton DF, Stratton M, Narod S, Goldgar D et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62:676–689

    Article  PubMed  CAS  Google Scholar 

  4. Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF et al (1999) The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. Am J Hum Genet 65:1021–1029

    Article  PubMed  CAS  Google Scholar 

  5. Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA (1998) A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol 105:493–499

    Article  PubMed  CAS  Google Scholar 

  6. Antoniou AC, Easton DF (2006) Risk prediction models for familial breast cancer. Future Oncol 2:257–274

    Article  PubMed  Google Scholar 

  7. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF et al (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33–36

    Article  PubMed  CAS  Google Scholar 

  8. Dicioccio RA, Song H, Waterfall C, Kimura MT, Nagase H et al (2004) STK15 polymorphisms and association with risk of invasive ovarian cancer. Cancer Epidemiol Biomark Prev 13:1589–1594

    CAS  Google Scholar 

  9. Auranen A, Song H, Waterfall C, Dicioccio RA, Kuschel B et al (2005) Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. Int J Cancer 117(6):611–618

    Article  PubMed  CAS  Google Scholar 

  10. Song H, Ramus SJ, Shadforth D, Quaye L, Kjaer SK et al (2006) Common variants in RB1 gene and risk of invasive ovarian cancer. Cancer Res 66(20):10220–10226

    Article  PubMed  CAS  Google Scholar 

  11. Song H, Ramus SJ, Kjaer SK, Hogdall E, Dicioccio RA et al (2007) Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer. PLoS ONE 2(3):e268

    Article  PubMed  Google Scholar 

  12. Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS et al (2007) Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 67(7):3027–3035

    Article  PubMed  CAS  Google Scholar 

  13. Hu JJ, Smith TR, Miller MS, Lohman K, Case LD (2002) Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ Mol Mutagen 39:208–215

    Article  PubMed  CAS  Google Scholar 

  14. Parshad R, Price FM, Bohr VA, Cowans KH, Zujewski JA, Sanford KK (1996) Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer 74(1):1–5

    Article  PubMed  CAS  Google Scholar 

  15. Debniak T, Scott RJ, Huzarski T, Byrski T, Masojc B, van de Wetering T, Serrano-Fernandez P, Gorski B, Cybulski C, Gronwald J, Debniak B, Maleszka R, Kladny J, Bieniek A, Nagay L, Haus O, Grzybowska E, Wandzel P, Niepsuj S, Narod SA, Lubinski J (2006) XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res Treat 98:209–215

    Article  PubMed  CAS  Google Scholar 

  16. de Boer JG (2002) Polymorphisms in DNA repair and environmental interactions. Mutat Res 509:201–210

    Article  PubMed  Google Scholar 

  17. Berwick M, Vineis P (2000) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 92:874–897

    Article  PubMed  CAS  Google Scholar 

  18. Costa S, Pinto D, Pereira D, Vasconcelos A, Afonso-Lopes C, Osorio T, Lopes C, Medeiros R (2007) Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer. Cancer Lett 246:324–330

    Article  PubMed  CAS  Google Scholar 

  19. Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, Bell DA (2000) XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 21:551–555

    Article  PubMed  CAS  Google Scholar 

  20. Tang D, Cho S, Rundle A, Chen S, Phillips D, Zhou J, Hsu Y, Schnabel F, Estabrook A, Perera FP (2002) Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAHDNA adducts in a case-control study of breast cancer. Breast Cancer Res Treat 75:159–166

    Article  PubMed  CAS  Google Scholar 

  21. Justenhoven C, Hamann U, Pesch B, Harth V, Rabstein S, Baisch C, Vollmert C, Illig T, Ko YD, Bruning T, Brauch H (2004) ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomark Prev 13:2059–2064

    CAS  Google Scholar 

  22. Silva SN, Tomar M, Paulo C, Gomes BC, Azevedo AP, Teixeira V, Pina JE, Rueff J, Gaspar JF (2010) Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. Cancer Epidemiol 34(1):85–92

    Article  PubMed  CAS  Google Scholar 

  23. Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J (2009) Validating genetic risk associations for ovarian cancer through the international ovarian cancer association consortium. Br J Cancer 100(2):412–420

    Article  PubMed  CAS  Google Scholar 

  24. Funk JO (1999) Cancer cell cycle control. Anticancer Res 19:4772–4780

    PubMed  CAS  Google Scholar 

  25. Lundberg AS, Weinberg RA (1999) Control of the cell cycle and apoptosis. Eur J Cancer 35:1886–1894

    Article  PubMed  CAS  Google Scholar 

  26. Sutherland RL, Musgrove EA (2004) Cyclins and breast cancer. J Mammary Gland Biol Neoplasia 9:95–104

    Article  PubMed  Google Scholar 

  27. Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Phelan CM, Anderson S, Rider DN, White KL, Pankratz VS (2009) Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Cancer Epidemiol Biomark Prev. 18(3):935–944

    Article  CAS  Google Scholar 

  28. Bernard-Gallon D, Bosviel R, Delort L, Fontana L, Chamoux A, Rabiau N, Kwiatkowski F, Chalabi N, Satih S, Bignon YJ (2008) DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk. Mol Cancer 7:36

    Article  PubMed  Google Scholar 

  29. Costa S, Pinto D, Pereira D, Vasconcelos A, Afonso-Lopes C, Osório T, Lopes C, Medeiros R (2006) Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer. Cancer Lett 246(1–2):324–330

    PubMed  Google Scholar 

  30. Quaye L, Tyrer J, Ramus SJ, Song H, Wozniak E, DiCioccio RA, McGuire V, Høgdall E, Høgdall C, Blaakaer J, Goode EL, Schildkraut JM, Easton DF, Krüger-Kjaer S, Whittemore AS, Gayther SA, Pharoah PD (2009) Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer. PLoS ONE 4(6):e5983

    Article  PubMed  Google Scholar 

  31. Fasching PA, Gayther S, Pearce L, Schildkraut JM, Goode E, Thiel F, Chenevix-Trench G, Chang-Claude J, Wang-Gohrke S, Ramus S, Pharoah P, Berchuck A, OCAC (Ovarian Cancer Association Consortium) (2009) Role of genetic polymorphisms and ovarian cancer susceptibility. Mol Oncol 3(2):171–181

    Article  PubMed  CAS  Google Scholar 

  32. Jin X, Kang S, Wang N, Xing YP, Li Y (2008) Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer. Zhonghua Fu Chan Ke Za Zhi 43(3):209–212

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biochemistry Division, Chemistry Department, Faculty of Sciences, Zagazig University, Zagazig, Egypt

    Faten Zahran Mohamed & Noha Mohamed Said

  2. Medical Biochemistry Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Yousry Mostafa Hussien & Randa H. Mohamed

  3. Obstetric and Gynecology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Mohamad Mohamad AlBakry

Authors
  1. Faten Zahran Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yousry Mostafa Hussien
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohamad Mohamad AlBakry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Randa H. Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Noha Mohamed Said
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Noha Mohamed Said.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mohamed, F.Z., Hussien, Y.M., AlBakry, M.M. et al. Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility. Mol Biol Rep 40, 3757–3768 (2013). https://doi.org/10.1007/s11033-012-2452-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-2452-8

Keywords

Search

Navigation